Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells

Immune checkpoint inhibitors (CI) have demonstrated clinical activity in Hodgkin Lymphoma (HL) patients relapsing after autologous stem cell transplantation (ASCT), although only 20% complete response (CR) rate was observed. The efficacy of CI is strictly related to the host immune competence, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Guolo, Fabio, Minetto, Paola, Pesce, Silvia, Ballerini, Filippo, Clavio, Marino, Cea, Michele, Frello, Michela, Garibotto, Matteo, Greppi, Marco, Bozzo, Matteo, Miglino, Maurizio, Passannante, Monica, Marcolin, Riccardo, Tedone, Elisabetta, Colombo, Nicoletta, Mangerini, Rosa, Bo, Alessandra, Ruzzenenti, Maria Rosaria, Carlier, Paolo, Serio, Alberto, Luchetti, Silvia, Dominietto, Alida, Varaldo, Riccardo, Candiani, Simona, Agostini, Vanessa, Ravetti, Jean Louis, Del Zotto, Genny, Marcenaro, Emanuela, Lemoli, Roberto Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603402/
https://www.ncbi.nlm.nih.gov/pubmed/34804039
http://dx.doi.org/10.3389/fimmu.2021.753890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603402/
https://www.ncbi.nlm.nih.gov/pubmed/34804039
http://dx.doi.org/10.3389/fimmu.2021.753890

Ejemplares similares